Gastrin regulates growth of human pancreatic cancer in a tonic and autocrine fashion

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The gastrointestinal nentides Eras-trin and cholecystokinin (CCK) stimulate growth of human pancreatic cancer through a CCK-B/gastrin-like receptor. In the present study we evaluated whether growth of human pancreatic cancer is endogenously regulated by gastrin. Immunohistochemical examination of BxPC-3 cells and tumor xenografts revealed specific gastrin immunoreactivity. Gastrin was detected by radioimmunoassay in pancreatic cancer cell extracts and in the growth media. With use of reversetranscriptase polymerase chain reaction gastrin gene expression was detected in both cultured BxPC-3 cancer cells and transplanted tumors, as well as seven additional human pancreatic cancer cell lines. Growth of BxPC-3 human pancreatic cancer cells in serum-free medium was inhibited by the addition of the CCK-B/gastrin receptor antagonist L-365,260, and gastrin treatment reversed the inhibitory effect of the antagonist. A selective gastrin antibody (Ab 2604) also repressed growth of BxPC-3 cells. Gastrin immunoreactivity was detected in fresh human pancreatic cancer specimens but not in normal human pancreatic tissue. These data provide the first evidence that growth of a human pancreatic cancer is tonically stimulated by the autocrine production of gastrin. Evidence for the ubiquity of this system was provided by the detection of gastrin gene expression in multiple human pancreatic cancer cell lines and detection of gastrin in cell lines and fresh pancreatic tumors. peptides; cholecystokinin B/gastrin receptor; L-365,260; neoplasia

Original languageEnglish (US)
JournalAmerican Journal of Physiology
Volume270
Issue number5 PART 2
StatePublished - Dec 1 1996

Fingerprint

Gastrins
Pancreatic Neoplasms
Cholecystokinin B Receptor
Growth
Cholecystokinin
Neoplasms
Cell Line
Gene Expression
Gastrin-Secreting Cells
Serum-Free Culture Media
Cell Extracts
Heterografts
Radioimmunoassay
Polymerase Chain Reaction
Peptides
Antibodies

All Science Journal Classification (ASJC) codes

  • Physiology (medical)

Cite this

@article{6f9f5cc01d614ba696eb9570a57288e6,
title = "Gastrin regulates growth of human pancreatic cancer in a tonic and autocrine fashion",
abstract = "The gastrointestinal nentides Eras-trin and cholecystokinin (CCK) stimulate growth of human pancreatic cancer through a CCK-B/gastrin-like receptor. In the present study we evaluated whether growth of human pancreatic cancer is endogenously regulated by gastrin. Immunohistochemical examination of BxPC-3 cells and tumor xenografts revealed specific gastrin immunoreactivity. Gastrin was detected by radioimmunoassay in pancreatic cancer cell extracts and in the growth media. With use of reversetranscriptase polymerase chain reaction gastrin gene expression was detected in both cultured BxPC-3 cancer cells and transplanted tumors, as well as seven additional human pancreatic cancer cell lines. Growth of BxPC-3 human pancreatic cancer cells in serum-free medium was inhibited by the addition of the CCK-B/gastrin receptor antagonist L-365,260, and gastrin treatment reversed the inhibitory effect of the antagonist. A selective gastrin antibody (Ab 2604) also repressed growth of BxPC-3 cells. Gastrin immunoreactivity was detected in fresh human pancreatic cancer specimens but not in normal human pancreatic tissue. These data provide the first evidence that growth of a human pancreatic cancer is tonically stimulated by the autocrine production of gastrin. Evidence for the ubiquity of this system was provided by the detection of gastrin gene expression in multiple human pancreatic cancer cell lines and detection of gastrin in cell lines and fresh pancreatic tumors. peptides; cholecystokinin B/gastrin receptor; L-365,260; neoplasia",
author = "Patricia McLaughlin and Ian Zagon",
year = "1996",
month = "12",
day = "1",
language = "English (US)",
volume = "270",
journal = "American Journal of Physiology",
issn = "0002-9513",
publisher = "American Physiological Society",
number = "5 PART 2",

}

Gastrin regulates growth of human pancreatic cancer in a tonic and autocrine fashion. / McLaughlin, Patricia; Zagon, Ian.

In: American Journal of Physiology, Vol. 270, No. 5 PART 2, 01.12.1996.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Gastrin regulates growth of human pancreatic cancer in a tonic and autocrine fashion

AU - McLaughlin, Patricia

AU - Zagon, Ian

PY - 1996/12/1

Y1 - 1996/12/1

N2 - The gastrointestinal nentides Eras-trin and cholecystokinin (CCK) stimulate growth of human pancreatic cancer through a CCK-B/gastrin-like receptor. In the present study we evaluated whether growth of human pancreatic cancer is endogenously regulated by gastrin. Immunohistochemical examination of BxPC-3 cells and tumor xenografts revealed specific gastrin immunoreactivity. Gastrin was detected by radioimmunoassay in pancreatic cancer cell extracts and in the growth media. With use of reversetranscriptase polymerase chain reaction gastrin gene expression was detected in both cultured BxPC-3 cancer cells and transplanted tumors, as well as seven additional human pancreatic cancer cell lines. Growth of BxPC-3 human pancreatic cancer cells in serum-free medium was inhibited by the addition of the CCK-B/gastrin receptor antagonist L-365,260, and gastrin treatment reversed the inhibitory effect of the antagonist. A selective gastrin antibody (Ab 2604) also repressed growth of BxPC-3 cells. Gastrin immunoreactivity was detected in fresh human pancreatic cancer specimens but not in normal human pancreatic tissue. These data provide the first evidence that growth of a human pancreatic cancer is tonically stimulated by the autocrine production of gastrin. Evidence for the ubiquity of this system was provided by the detection of gastrin gene expression in multiple human pancreatic cancer cell lines and detection of gastrin in cell lines and fresh pancreatic tumors. peptides; cholecystokinin B/gastrin receptor; L-365,260; neoplasia

AB - The gastrointestinal nentides Eras-trin and cholecystokinin (CCK) stimulate growth of human pancreatic cancer through a CCK-B/gastrin-like receptor. In the present study we evaluated whether growth of human pancreatic cancer is endogenously regulated by gastrin. Immunohistochemical examination of BxPC-3 cells and tumor xenografts revealed specific gastrin immunoreactivity. Gastrin was detected by radioimmunoassay in pancreatic cancer cell extracts and in the growth media. With use of reversetranscriptase polymerase chain reaction gastrin gene expression was detected in both cultured BxPC-3 cancer cells and transplanted tumors, as well as seven additional human pancreatic cancer cell lines. Growth of BxPC-3 human pancreatic cancer cells in serum-free medium was inhibited by the addition of the CCK-B/gastrin receptor antagonist L-365,260, and gastrin treatment reversed the inhibitory effect of the antagonist. A selective gastrin antibody (Ab 2604) also repressed growth of BxPC-3 cells. Gastrin immunoreactivity was detected in fresh human pancreatic cancer specimens but not in normal human pancreatic tissue. These data provide the first evidence that growth of a human pancreatic cancer is tonically stimulated by the autocrine production of gastrin. Evidence for the ubiquity of this system was provided by the detection of gastrin gene expression in multiple human pancreatic cancer cell lines and detection of gastrin in cell lines and fresh pancreatic tumors. peptides; cholecystokinin B/gastrin receptor; L-365,260; neoplasia

UR - http://www.scopus.com/inward/record.url?scp=33745430380&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745430380&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33745430380

VL - 270

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0002-9513

IS - 5 PART 2

ER -